Medical Cannabis for Drug-Resistant Epilepsy - Facts, Not Hopes

Epilepsy is an area where medical cannabis has some of the strongest evidence - but also one where misunderstanding comes easily. The key: it's about CBD, not THC, and about specific, severe forms of drug-resistant epilepsy, not every case.

Below we separate facts from hopes: where cannabis genuinely helps in epilepsy, why a neurologist leads it, and what you absolutely must not do on your own.

The strongest data concern CBD (cannabidiol) in rare, severe drug-resistant epilepsies: Dravet syndrome, Lennox-Gastaut syndrome and tuberous sclerosis. In these indications purified CBD as a medicine (Epidiolex) is registered and reduces seizure frequency.

That's a real, documented effect - but in a narrow scope. CBD isn't a medicine for every epilepsy, and in typical, well-controlled epilepsy there's no basis to add it.

In epilepsy the anticonvulsant effect is attributed to CBD. THC is a different story - in some situations it may even lower the seizure threshold, which is why it's approached very cautiously in epilepsy.

That's why this isn't about "marijuana" in the casual sense, but a precisely chosen CBD-dominant preparation, under specialist supervision.

Drug-resistant epilepsy is the domain of a neurologist and epileptologist. CBD-based therapy is part of specialist-led treatment, matched to the specific epilepsy syndrome and the other antiepileptic drugs.

Don't stop antiepileptic drugs and don't add anything on your own - in epilepsy abrupt changes can be dangerous. Every modification is set with your treating doctor.

If you or someone close struggles with drug-resistant epilepsy and you're considering CBD, the best step is a conversation with the treating neurologist plus a consultation that assesses whether and how to add a cannabis preparation within the treatment.

Book a visit in person in Krakow, Bydgoszcz and Toruń, phone: +48 731 000 645. Where the CBD-THC differences come from is in our article on THC and CBD.